DSpace About DSpace Software DSpace
 

Repository KhNMU >
Кафедри >
Кафедра внутрішньої медицини № 1 >
Наукові роботи молодих вчених. Кафедра внутрішньої медицини № 1 >

Please use this identifier to cite or link to this item: http://repo.knmu.edu.ua/handle/123456789/18814

Название: Metabolic drugs in anti-ischemic therapy
Авторы: Захаренкова, Анастасія Володимирівна
Візір, Марина Олександрівна
Vizir, Maryna
Визир, Марина Александровна
Ключевые слова: anti-ischemic therapy
coronary heart disease
trimetazidine
thiotriazoline
Issue Date: Nov-2017
Издатель: Skleněný Můstek, Karlovy Vary, Czech Republic
Библиографическое описание: Zakharenkova A. Metabolic drugs in anti-ischemic therapy / A. Zakharenkova // SCIENCE AND LIFE: Proceedings of articles the international scientific conference, Skleněný Můstek, Karlovy Vary, Czech Republic, 16-17 November 2017. - Karlovy Vary, 2017. - P. 59-64.
Аннотация: The first drugs for anti-ischemic therapy were vitamins of group B, but their effectiveness was refuted in clinical trials. The next drug was trimetazidine, since it has a high cytoprotective effect. This drug is especially effective in patients with stable angina. But thiotriazoline is a new anti-ischemic drug that includes anti-ischemic, metabolic and antioxidant activity with minimal side effects. Summing up, given the good tolerability, efficacy and safety, thiotriazoline can be recommended as a remedy of metabolic therapy for the treatment of IHD in the elderly.
URI: http://repo.knmu.edu.ua/handle/123456789/18814
Appears in Collections:Наукові роботи молодих вчених. Кафедра внутрішньої медицини № 1

Files in This Item:

File Description SizeFormat
Статья Захаренкова.docx25,26 kBMicrosoft Word XMLView/Open


This item is protected by original copyright

View Statistics

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback